Bayer Gets FDA Approval for Advanced Prostate Cancer Drug

The drug, which will be sold with the brand name Xofigo, is meant to treat prostate cancer that has spread to the bones, but not other organs, in men who have previously received separate therapy designed to lower testosterone. Testosterone is a hormone that can stimulate prostate cancer growth.